• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种NEF衍生脂肽并感染致病性SIVmac251的恒河猴中的SIV逃逸突变体

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251.

作者信息

Villefroy Pascale, Letourneur Franck, Coutsinos Zoe, Mortara Lorenzo, Beyer Christian, Gras-Masse Helene, Guillet Jean-Gerard, Bourgault-Villada Isabelle

机构信息

Institut Cochin, Département d'Immunologie, Hôpital Cochin, 27, rue du Faubourg Saint-Jacques, Paris, F-75014, France.

出版信息

Virol J. 2006 Aug 31;3:65. doi: 10.1186/1743-422X-3-65.

DOI:10.1186/1743-422X-3-65
PMID:16945152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1613241/
Abstract

BACKGROUND

Emergence of viral variants that escape CTL control is a major hurdle in HIV vaccination unless such variants affect gene regions that are essential for virus replication. Vaccine-induced multispecific CTL could also be able to control viral variants replication. To explore these possibilities, we extensively characterized CTL responses following vaccination with an epitope-based lipopeptide vaccine and challenge with pathogenic SIVmac251. The viral sequences corresponding to the epitopes present in the vaccine as well as the viral loads were then determined in every macaque following SIV inoculation.

RESULTS

In most cases, the emergence of several viral variants or mutants within vaccine CTL epitopes after SIV challenge resulted in increased viral loads except for a single macaque, which showed a single escape viral variant within its 6 vaccine-induced CTL epitopes.

CONCLUSION

These findings provide a better understanding of the evolution of CD8+ epitope variations after vaccination-induced CTL expansion and might provide new insight for the development of an effective HIV vaccine.

摘要

背景

除非病毒变异体影响病毒复制所必需的基因区域,否则逃避细胞毒性T淋巴细胞(CTL)控制的病毒变异体的出现是HIV疫苗接种的主要障碍。疫苗诱导的多特异性CTL也可能能够控制病毒变异体的复制。为了探索这些可能性,我们广泛地表征了接种基于表位的脂肽疫苗后以及用致病性SIVmac251攻击后的CTL反应。然后在每只猕猴接种SIV后测定与疫苗中存在的表位相对应的病毒序列以及病毒载量。

结果

在大多数情况下,SIV攻击后疫苗CTL表位内出现几种病毒变异体或突变体导致病毒载量增加,但有一只猕猴除外,该猕猴在其6个疫苗诱导的CTL表位内仅出现了一个逃逸病毒变异体。

结论

这些发现有助于更好地理解接种疫苗诱导的CTL扩增后CD8 +表位变异的演变,并可能为开发有效的HIV疫苗提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3b/1613241/88ad3edcfa78/1743-422X-3-65-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3b/1613241/0e23f102b18e/1743-422X-3-65-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3b/1613241/cd51b60b25ab/1743-422X-3-65-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3b/1613241/88ad3edcfa78/1743-422X-3-65-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3b/1613241/0e23f102b18e/1743-422X-3-65-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3b/1613241/cd51b60b25ab/1743-422X-3-65-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3b/1613241/88ad3edcfa78/1743-422X-3-65-3.jpg

相似文献

1
SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251.接种NEF衍生脂肽并感染致病性SIVmac251的恒河猴中的SIV逃逸突变体
Virol J. 2006 Aug 31;3:65. doi: 10.1186/1743-422X-3-65.
2
Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.猕猴脂肽免疫和猴免疫缺陷病毒攻击后Nef表位细胞毒性T淋巴细胞识别的暂时丧失
Virology. 2000 Dec 20;278(2):551-61. doi: 10.1006/viro.2000.0671.
3
DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses.用几种不同的Nef序列对猕猴进行DNA疫苗接种可诱导多特异性T细胞反应。
Virology. 2001 Jan 5;279(1):136-45. doi: 10.1006/viro.2000.0705.
4
Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.在SIVmac-猕猴模型中通过多基因DNA启动和腺病毒加强免疫降低病毒载量
Vaccine. 2006 Mar 10;24(11):1811-20. doi: 10.1016/j.vaccine.2005.10.026. Epub 2005 Oct 25.
5
Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques.多表位特异性细胞毒性T淋巴细胞反应参与基于疫苗的恒河猴猿猴免疫缺陷病毒复制控制
J Virol. 2006 Feb;80(4):1949-58. doi: 10.1128/JVI.80.4.1949-1958.2006.
6
Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.口服SIVmac239攻击后,接种疫苗的猕猴长期存活,无论慢性期病毒血症是否得到控制。
Vaccine. 2008 Dec 2;26(51):6690-8. doi: 10.1016/j.vaccine.2008.07.055.
7
Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.用复制型腺病毒-SIV多基因初免/蛋白加强疫苗方案免疫的恒河猴对第二次SIVmac251直肠攻击的持久保护:SIV特异性CD8 + T细胞反应的作用
Virology. 2006 Sep 15;353(1):83-98. doi: 10.1016/j.virol.2006.05.012. Epub 2006 Jun 30.
8
Novel simian immunodeficiency virus CTL epitopes restricted by MHC class I molecule Mamu-B*01 are highly conserved for long term in DNA/MVA-vaccinated, SHIV-challenged rhesus macaques.受MHC I类分子Mamu - B*01限制的新型猿猴免疫缺陷病毒CTL表位在经DNA/MVA疫苗接种并受到SHIV攻击的恒河猴中长期高度保守。
Int Immunol. 2005 May;17(5):637-48. doi: 10.1093/intimm/dxh245. Epub 2005 Apr 11.
9
Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.在感染猴免疫缺陷病毒后诱导疫苗抗原特异性细胞毒性 T 淋巴细胞反应。
Biochem Biophys Res Commun. 2011 May 20;408(4):615-9. doi: 10.1016/j.bbrc.2011.04.071. Epub 2011 Apr 21.
10
Inclusion of Vpr accessory gene in a plasmid vaccine cocktail markedly reduces Nef vaccine effectiveness in vivo resulting in CD4 cell loss and increased viral loads in rhesus macaques.在质粒疫苗组合中包含Vpr辅助基因会显著降低Nef疫苗在体内的有效性,导致恒河猴体内CD4细胞减少和病毒载量增加。
J Med Primatol. 2002 Aug;31(4-5):179-85. doi: 10.1034/j.1600-0684.2002.02004.x.

引用本文的文献

1
Mechanisms of viral emergence.病毒出现的机制。
Vet Res. 2010 Nov-Dec;41(6):38. doi: 10.1051/vetres/2010010. Epub 2010 Feb 5.
2
Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials.摆弄HIV疫苗:利用恒河猴为临床试验确定“把关因素”
Nat Rev Immunol. 2009 Oct;9(10):717-28. doi: 10.1038/nri2636.

本文引用的文献

1
Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11.CD8 + 细胞在控制非致病性猿猴免疫缺陷病毒SIVmac1A11复制中的作用。
Virol J. 2006 Apr 3;3:22. doi: 10.1186/1743-422X-3-22.
2
Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.在一项临床前艾滋病疫苗试验中,基于细胞毒性T淋巴细胞对猿猴免疫缺陷病毒复制的控制。
J Exp Med. 2004 Jun 21;199(12):1709-18. doi: 10.1084/jem.20040432.
3
Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys.
在接种DNA疫苗的恒河猴中,病毒从主要的猿猴免疫缺陷病毒表位特异性细胞毒性T淋巴细胞中逃逸。
J Virol. 2003 Jul;77(13):7367-75. doi: 10.1128/jvi.77.13.7367-7375.2003.
4
Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.针对整个表达的人类免疫缺陷病毒1型(HIV-1)基因组的HIV-1特异性T细胞反应的综合表位分析显示出广泛的反应,但与病毒载量无关。
J Virol. 2003 Feb;77(3):2081-92. doi: 10.1128/jvi.77.3.2081-2092.2003.
5
Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.HIV感染中记忆性HIV特异性细胞毒性T细胞广度、病毒载量与疾病进展之间的相关性。
AIDS. 2002 Dec 6;16(18):2399-407. doi: 10.1097/00002030-200212060-00004.
6
HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate.一名早产新生儿感染后儿科慢进展者中的HIV-1特异性CD8 T细胞反应
AIDS. 2002 Oct 18;16(15):2085-7. doi: 10.1097/00002030-200210180-00017.
7
Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection.针对单个猴免疫缺陷病毒(SIV)Gag细胞毒性T淋巴细胞(CTL)表位对SIVmac239感染进程的影响。
J Virol. 2002 Oct;76(20):10507-11. doi: 10.1128/jvi.76.20.10507-10511.2002.
8
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.恒河猴中因病毒逃避细胞毒性T淋巴细胞导致艾滋病疫苗最终失效。
Nature. 2002 Jan 17;415(6869):335-9. doi: 10.1038/415335a.
9
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.无复制能力的腺病毒疫苗载体可引发有效的抗免疫缺陷病毒免疫力。
Nature. 2002 Jan 17;415(6869):331-5. doi: 10.1038/415331a.
10
ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.基于金丝雀痘病毒载体-猴免疫缺陷病毒gag-pol-env的疫苗接种以及猕猴主要组织相容性复合体I类(A*01)延缓猴免疫缺陷病毒SIVmac诱导的免疫缺陷。
J Virol. 2002 Jan;76(1):292-302. doi: 10.1128/jvi.76.1.292-302.2002.